<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:ynews="http://news.yahoo.com/rss/">
<channel>
<title>Yahoo! News: Business - Pharmaceutical</title>
<copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright>
<link>http://news.yahoo.com/i/1190</link>
<category>business</category>
<description>Business - Pharmaceutical</description>
<language>en-us</language> 
<lastBuildDate>Fri, 20 Nov 2009 18:28:10 GMT</lastBuildDate>
<ttl>5</ttl> 
<image>
<title>Yahoo! News</title>
<width>142</width>
<height>18</height>
<link>http://news.yahoo.com/i/1190</link>
<url>http://l.yimg.com/a/i/us/nws/th/main_142b.gif</url>
</image>
<item>
<title>Warrant: Drug in Jackson case came from Vegas firm 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091120/ap_on_re_us/us_michael_jackson_doctor</link>
 <guid isPermaLink="false">ap/20091120/us_michael_jackson_doctor</guid>
<source>AP</source>
<category>us</category>
<pubDate>Fri, 20 Nov 2009 18:28:10 GMT</pubDate>
<description>AP - Court documents show police linked a drug blamed in Michael Jackson&#039;s death to the pop singer&#039;s personal physician who bought it at a Las Vegas pharmacy.</description>
</item>
<item>
<title>BioCryst prices stock offering at &#36;9.75 per share 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091120/ap_on_bi_ge/us_biocryst_pharmaceuticals_offering</link>
 <guid isPermaLink="false">ap/20091120/us_biocryst_pharmaceuticals_offering</guid>
<source>AP</source>
<category>business</category>
<pubDate>Fri, 20 Nov 2009 15:17:51 GMT</pubDate>
<description>AP - Flu drug developer BioCryst Pharmaceuticals Inc. priced its 5 million common stock share offering at &#36;9.75 per share.</description>
</item>
<item>
<title>FDA issues warnings to Web sites over drug sales 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091119/ap_on_bi_ge/us_fda_illegal_pharmaceutical_sales</link>
 <guid isPermaLink="false">ap/20091119/us_fda_illegal_pharmaceutical_sales</guid>
<source>AP</source>
<category>business</category>
<pubDate>Thu, 19 Nov 2009 20:36:25 GMT</pubDate>
<description>AP - The Food and Drug Administration said Thursday it issued 22 warning letters to Web site operators over alleged illegal sales of unapproved or misbranded drugs.</description>
</item>
<item>
<title>Momenta rises on upgrade ahead of Lovenox ruling 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091119/ap_on_bi_ge/us_momenta_pharma_mover</link>
 <guid isPermaLink="false">ap/20091119/us_momenta_pharma_mover</guid>
<source>AP</source>
<category>business</category>
<pubDate>Thu, 19 Nov 2009 18:31:04 GMT</pubDate>
<description>AP - Shares of Momenta Pharmaceuticals Inc. rose Thursday after an analyst upgraded the stock, saying Momenta will soon receive marketing approval for its version of the anti-clotting drug Lovenox.</description>
</item>
<item>
<title>Ligand receives &#36;2 million from Merck partnership 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091119/ap_on_bi_ge/us_ligand_pharmaceuticals_contract</link>
 <guid isPermaLink="false">ap/20091119/us_ligand_pharmaceuticals_contract</guid>
<source>AP</source>
<category>business</category>
<pubDate>Thu, 19 Nov 2009 18:23:22 GMT</pubDate>
<description>AP - Ligand Pharmaceuticals Inc. said Thursday it received a &#36;2 million milestone payment from Merck &amp; Co. as part of a research collaboration.</description>
</item>
<item>
<title>PPD buying BioDuro in China expansion 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091118/ap_on_bi_ge/us_ppd_acquisition</link>
 <guid isPermaLink="false">ap/20091118/us_ppd_acquisition</guid>
<source>AP</source>
<category>business</category>
<pubDate>Wed, 18 Nov 2009 22:27:10 GMT</pubDate>
<description>AP - Drug development contractor Pharmaceutical Product Development Inc. said Wednesday it will buy BioDuro LLC in a move to expand capabilities in China.</description>
</item>
<item>
<title>Delcath Systems share offering raises &#36;32 million 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091118/ap_on_bi_ge/us_delcath_share_offering</link>
 <guid isPermaLink="false">ap/20091118/us_delcath_share_offering</guid>
<source>AP</source>
<category>business</category>
<pubDate>Wed, 18 Nov 2009 20:17:02 GMT</pubDate>
<description>AP - Delcath Systems Inc., a developer of a cancer-drug delivery device, said Wednesday it raised &#36;32.4 million in net proceeds from a public stock offering.</description>
</item>
<item>
<title>Ex-pharma executive runs as Dem for Kan. governor 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091118/ap_on_bi_ge/us_kansas_governor</link>
 <guid isPermaLink="false">ap/20091118/us_kansas_governor</guid>
<source>AP</source>
<category>business</category>
<pubDate>Wed, 18 Nov 2009 16:33:06 GMT</pubDate>
<description>AP - A former pharmaceutical company executive who returned to Kansas this year announced Tuesday that he&#039;s running for governor, giving Democrats a declared candidate.</description>
</item>
<item>
<title>Vaccines on horizon for AIDS, Alzheimer&#039;s, herpes 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091118/ap_on_sc/us_vaccine_revolution</link>
 <guid isPermaLink="false">ap/20091118/us_vaccine_revolution</guid>
<source>AP</source>
<category>health</category>
<pubDate>Wed, 18 Nov 2009 08:52:07 GMT</pubDate>
<description>AP - Malaria. Tuberculosis. Alzheimer&#039;s disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler&#039;s diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.</description>
</item>
<item>
<title>Poniard rebounds on picoplatin colon cancer data 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091117/ap_on_bi_ge/us_poniard_pharma_picoplatin</link>
 <guid isPermaLink="false">ap/20091117/us_poniard_pharma_picoplatin</guid>
<source>AP</source>
<category>business</category>
<pubDate>Tue, 17 Nov 2009 18:57:33 GMT</pubDate>
<description>AP - A day after Poniard Pharmaceuticals Inc. said its drug candidate picoplatin failed to improve survival for patients with lung cancer, the company reported positive data on the drug as a treatment for colorectal cancer.</description>
</item>
<item>
<title>BioCryst Pharma to sell up to 5.75M new shares 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091117/ap_on_bi_ge/us_biocryst_pharma_stock_offer</link>
 <guid isPermaLink="false">ap/20091117/us_biocryst_pharma_stock_offer</guid>
<source>AP</source>
<category>business</category>
<pubDate>Tue, 17 Nov 2009 12:39:09 GMT</pubDate>
<description>AP - Flu drug developer BioCryst Pharmaceuticals Inc. said Tuesday it plans to sell as many as 5.75 million new shares of stock.</description>
</item>
<item>
<title>Novartis: lower dose of flu vaccine sufficient 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091117/ap_on_bi_ge/eu_switzerland_novartis_vaccine</link>
 <guid isPermaLink="false">ap/20091117/eu_switzerland_novartis_vaccine</guid>
<source>AP</source>
<category>business</category>
<pubDate>Tue, 17 Nov 2009 11:57:37 GMT</pubDate>
<description>AP - Pharmaceutical maker Novartis AG said Tuesday a U.S. clinical study suggests that half a dose of its swine flu vaccine may be sufficient to protect people from the virus and could allow many more to be immunized with current supplies.</description>
</item>
<item>
<title>More doubts over Merck anti-cholesterol drug: study 
    (AFP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20091116/ts_alt_afp/healthdrugsmerck</link>
 <guid isPermaLink="false">afp/20091116/healthdrugsmerck</guid>
<source>AFP</source>
<category>us</category>
<pubDate>Mon, 16 Nov 2009 21:35:07 GMT</pubDate>
<description>&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20091116/ts_alt_afp/healthdrugsmerck">&#60;img src="http://d.yimg.com/a/p/afp/20091116/capt.photo_1258407245592-1-0.jpg?x=130&amp;y=81&amp;q=85&amp;sig=CGe8Hfz44mZchfLsOeMFrg--" align="left" height="81" width="130" alt="A car enters the employee entrace at the headquarters for drug maker Merck in Kenilworth, New Jersey. A new study has cast fresh doubt on the effectiveness of Zetia, a cholesterol drug produced by US pharmaceuticals giant Merck.(AFP/Getty Images/File/Chris Hondros)" border="0" />&#60;/a>AFP - A new study has cast fresh doubt on the effectiveness of Zetia, a cholesterol drug produced by US pharmaceuticals giant Merck.&#60;/p>&#60;br clear="all"/></description>
<media:content url="http://d.yimg.com/a/p/afp/20091116/capt.photo_1258407245592-1-0.jpg?x=130&amp;y=81&amp;q=85&amp;sig=CGe8Hfz44mZchfLsOeMFrg--" type="image/jpeg" height="81" width="130"/>
<media:text type="html">&#60;p>&#60;a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20091116/ts_alt_afp/healthdrugsmerck">&#60;img src="http://d.yimg.com/a/p/afp/20091116/capt.photo_1258407245592-1-0.jpg?x=130&amp;y=81&amp;q=85&amp;sig=CGe8Hfz44mZchfLsOeMFrg--" align="left" height="81" width="130" alt="photo" title="A car enters the employee entrace at the headquarters for drug maker Merck in Kenilworth, New Jersey. A new study has cast fresh doubt on the effectiveness of Zetia, a cholesterol drug produced by US pharmaceuticals giant Merck.(AFP/Getty Images/File/Chris Hondros)" border="0"/>&#60;/a>&#60;/p>&#60;br clear="all"/></media:text>
<media:credit role="publishing company">(AFP)</media:credit>
</item>
<item>
<title>Poniard plunges on failure of picoplatin study 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091116/ap_on_bi_ge/us_poniard_pharma_mover</link>
 <guid isPermaLink="false">ap/20091116/us_poniard_pharma_mover</guid>
<source>AP</source>
<category>business</category>
<pubDate>Mon, 16 Nov 2009 17:42:37 GMT</pubDate>
<description>AP - Shares of Poniard Pharmaceuticals Inc. crashed Monday after the company said its cancer drug picoplatin missed its goal in a clinical trial.</description>
</item>
<item>
<title>Par Pharma gets FDA approval for generic Ultram ER 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091116/ap_on_bi_ge/us_par_pharma_ultram_er</link>
 <guid isPermaLink="false">ap/20091116/us_par_pharma_ultram_er</guid>
<source>AP</source>
<category>business</category>
<pubDate>Mon, 16 Nov 2009 15:42:12 GMT</pubDate>
<description>AP - Par Pharmaceutical Co. said Monday it received marketing approval for a generic version of Johnson &amp; Johnson&#039;s extended-release chronic pain drug Ultram ER, and has started shipping the drug.</description>
</item>
<item>
<title>Poniard cancer drug misses goal in lung cancer 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091116/ap_on_bi_ge/us_poniard_pharma_picoplatin_trial</link>
 <guid isPermaLink="false">ap/20091116/us_poniard_pharma_picoplatin_trial</guid>
<source>AP</source>
<category>business</category>
<pubDate>Mon, 16 Nov 2009 14:07:12 GMT</pubDate>
<description>AP - Poniard Pharmaceuticals Inc. said Monday its cancer drug candidate picoplatin did not help lung cancer patients live longer, sending its shares plunging in early trading.</description>
</item>
<item>
<title>Lexicon says IBS drug met mid-stage study goal 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091113/ap_on_bi_ge/us_lexicon_pharma_ibs_drug</link>
 <guid isPermaLink="false">ap/20091113/us_lexicon_pharma_ibs_drug</guid>
<source>AP</source>
<category>business</category>
<pubDate>Fri, 13 Nov 2009 19:50:11 GMT</pubDate>
<description>AP - Lexicon Pharmaceuticals Inc. said Friday an irritable bowel syndrome drug candidate met its goals in a mid-stage clinical trial.</description>
</item>
<item>
<title>Eli Lilly head of research, development to retire 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091113/ap_on_bi_ge/us_eli_lilly_personnel</link>
 <guid isPermaLink="false">ap/20091113/us_eli_lilly_personnel</guid>
<source>AP</source>
<category>business</category>
<pubDate>Fri, 13 Nov 2009 16:12:52 GMT</pubDate>
<description>AP - Eli Lilly &amp; Co. said Friday its science and technology head will retire. The drugmaker hired the chief researcher at AstraZeneca PLC to replace him.</description>
</item>
<item>
<title>Serbia buys 3 million Swiss swine flu vaccines 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091113/ap_on_bi_ge/eu_serbia_swine_flu</link>
 <guid isPermaLink="false">ap/20091113/eu_serbia_swine_flu</guid>
<source>AP</source>
<category>business</category>
<pubDate>Fri, 13 Nov 2009 14:35:54 GMT</pubDate>
<description>AP - Serbia&#039;s health authorities have ordered three million swine flu vaccines from Swiss pharmaceutical company Novartis AG worth an estimated euro24 million (&#36;36 million).</description>
</item>
<item>
<title>Myriad Pharma posts smaller 1Q loss after spinoff 
    (AP)
</title>
 <link>http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091113/ap_on_bi_ge/us_earns_myriad_pharma</link>
 <guid isPermaLink="false">ap/20091113/us_earns_myriad_pharma</guid>
<source>AP</source>
<category>business</category>
<pubDate>Fri, 13 Nov 2009 11:54:43 GMT</pubDate>
<description>AP - Myriad Pharmaceuticals Inc. on Friday reported a smaller fiscal first-quarter loss on lower research costs after the company was spun off from Myriad Genetics Inc.</description>
</item>
</channel>
</rss>
<!-- server fe2.news.ac4.yahoo.com -->

